Ryan & Maniskas, LLP Announces Investigation of MEDTOX Scientific Inc.
05 Junio 2012 - 9:31AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/mtox) is
investigating potential claims against the board of directors of
MEDTOX Scientific Inc. (“MEDTOX” or the “Company”) (NASDAQ: MTOX)
concerning possible breaches of fiduciary duty and other violations
of law related to the Company’s efforts to sell MEDTOX to
Laboratory Corporation of America® Holdings in a transaction valued
at approximately $241 million.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by the Company’s board of directors; in particular,
whether the Company undertook a fair process to obtain fair
consideration for all shareholders of MEDTOX. For more information
regarding our investigation, please contact Ryan & Maniskas,
LLP (Richard A. Maniskas, Esquire) toll-free at (877) 316-3218 or
by email at rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/mtox.
Under the terms of the transaction, MEDTOX shareholders will
receive $27.00 for each share of MEDTOX stock they own.
If you own shares of MEDTOX and would like to learn more about
these claims or if you wish to discuss these matters and have any
questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign
up online, visit: www.rmclasslaw.com/cases/mtox. You may also email
Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information
about class action cases in general, please visit our website:
www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Medtox Scientific, Inc. (MM) (NASDAQ:MTOX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Medtox Scientific, Inc. (MM) (NASDAQ:MTOX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Medtox Scientific, Inc. (MM) (NASDAQ): 0 recent articles
Más de Ryan & Maniskas, LLP Artículos de Noticias